News|Articles|December 10, 2025

FDA Action Update, November 2025: Approvals, Clearance, and Boxed Warning

Catch up on any of the neurology news headlines you may have missed in November 2025, compiled into 1 place by the NeurologyLive® team.

The FDA was busy in November 2025, making a number of decisions on potential new therapeutic agents, including granting approvals and a clearance, issuing a complete response letter, adding a box warning, providing feedback, and reconsidering its stance on a submission.